The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.
Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.
Psychopharmacology is a swiftly evolving field, with new drugs coming onto the market and existing drugs being approved for new treatments at a rapid pace. This new edition of Clinical Manual of Addiction Psychopharmacology offers current information on the pharmacology of the major classes of drugs related to addiction, as well as the latest pharmacological treatment of dependence on these drugs. Advances have been made in the treatment of opioid, alcohol, and in particular tobacco dependence; and these chapters have been thoroughly updated accordingly. In addition, the manual reflects recent research findings and evidence-based perspectives on the pharmacological actions of other drugs of abuse.
The editors have adopted a therapeutic focus that will prove indispensable to clinicians challenged to identify effective pharmacotherapy treatments for their patients with substance use disorders. For example, the importance of identifying co-occurring medical problems and psychiatric syndromes is emphasized to avoid undermining the therapeutic effects of treatment, and the efficacy of combining nonpharmacological treatment, such as psychotherapy, is also explored. Prescribing clinicians, social workers, and other mental health practitioners will find Clinical Manual of Addiction Psychopharmacology invaluable in their work with individuals with substance-related disorders.